Transcription of コンドロイチンの臨床的有用性 - pha.jp
1 43, 44-48 (2014). - 44 - D- GlcA N- -D- GalNAc 2 GlcA-GalNAc GlcA 3 43, 44-48 (2014). - 45 - 6 3 200mg 1 20ml 200mg 2012 12 50 1 20ml 58 1 20ml 200mg 400mg 1960 6 1 20ml 1 3 1ml 10mg 30mg 1970 8 1 5ml 3 5ml AN 6 1
2 VB1 100mg VB6 20mg VB12 60 g 800mg 1.. 43, 44-48 (2014). - 46 - 2. B1 .. 3. 1 3 1 100 16 4,179 200 33 7,329 25 ZS 1 260mg 1 6 60 10 2,520 108 18 3,880 180 30 5,880 270 45 7,880 HP NSAIDs 1980 2001 2008 6 2 4 1 3 1 ZS 39 2011 11 CS OA OA CS Kellgren and Lawrence grade 2 3 VAS 30mm OA 73 12
3 61 CS 1 260mg 1,560mg 2 3 6 9 12 Lequesne index LI VAS 12 LI 43, 44-48 (2014). - 47 - 8 LI I 6 9 VAS 6 CS OA CS NSAIDs 1 260mg 6 1 50 89 1,500mg/ 1.
4 200mg/ 6 2 2010 6 4 200 10 3 NIH 2 6 43, 44-48 (2014). - 48 - 49 1 DLST 69 400mg 500mg 6cp/ 4 INR 5 71 1,500mg 1,200mg 1 2 3 INR 750mg/ 600mg/ INR INR NSAIDs 1 Rheumatol Int.
5 30(3) 357-363 (2010). 2 Osteoarthritis Cartilage, 15(11) 1256-1266 (2007). 3 BMJ, 16(1) 1-9(2010). ( )
